The European Innovation Council (EIC) and the European Medicine Agency (EMA) invite you to attend the EIC-EMA Info Day on January 31, 2023 to hear about the wide range of support services provided by EMA to researchers and SMEs active in research and innovation in the pharmaceutical and med-tech sectors.
EIC grantees and future EIC applicants are strongly encouraged to participate. The event is also open to researchers and SMEs funded by other EU programmes.
This event is relevant if:
You are you an innovator in the health-tech sector funded by the EIC or other EU programmes.
You are in the early development stage of a medical technology or pharmaceutical, and have not considered regulatory aspects of your innovation and support from authorities.
Your medical technology or pharmaceutical development is more advanced and you want to learn how to best apply to European Medicines Agency (EMA) services such as PRIME or Scientific Advice.
During the online Info Day, you will learn on how to engage with EMA at different development milestones, and on the range of EMA support services including those targeting gene and cell therapies, and orphan medicines. You will also hear about the benefits to apply to the Innovation Task Force (ITF) services, PRIME and Scientific Advice as well as practical details on how to prepare and submit applications. Moreover, you will hear real examples of advice given through these services and will testimonials from academic researchers and companies funded by the EIC Pathfinder and Accelerator programmes on their experience with EMA services.
The audience will and have the opportunity to ask live questions to the speakers via Sli.do, using the event code #EICEMA.
The event is free of charge and no registration is required: the Info Day will be broadcasted on this web page and on YouTube.
You can express your interest in following the event via the EISMEA LinkedIn account.
Discover the speakers who will join the event in the document below. A detailed agenda will shortly follow.
- pharmaceutical industry | medical science | innovation